Mortality and use of angiotensin converting enzyme inhibitors in Covid 19 disease – a systematic review
View ORCID ProfileJosé Pedro L. Nunes
doi: https://doi.org/10.1101/2020.05.29.20116483
José Pedro L. Nunes
1Faculdade de Medicina, Universidade do Porto, Porto, Portugal
2Department of Cardiology, Centro Hospitalar Universitário São João, Porto, Portugal
Data Availability
All data was obtained from the cited articles
Posted May 30, 2020.
Mortality and use of angiotensin converting enzyme inhibitors in Covid 19 disease – a systematic review
José Pedro L. Nunes
medRxiv 2020.05.29.20116483; doi: https://doi.org/10.1101/2020.05.29.20116483
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2887)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12631)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4493)
- Geriatric Medicine (411)
- Health Economics (718)
- Health Informatics (2874)
- Health Policy (1059)
- Hematology (381)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4263)
- Nursing (228)
- Nutrition (626)
- Oncology (2232)
- Ophthalmology (637)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6843)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)